Detailed Narrative
Strong Q1 FY26 Performance Driven by Market Recovery
Sharda Cropchem delivered a robust Q1 FY26, with total revenue growing by 25% year-on-year to ₹985 crores. This performance was primarily attributed to a global revival in demand and a recovery in pricing across the agrochemical market. Overall volume growth stood at 13%, indicating healthy underlying demand. The company's management highlighted that inventories have normalized across distribution channels, signaling a healthier market environment.
Significant Margin Expansion and Profitability Boost
The quarter saw a substantial expansion in profitability, with gross margins increasing by 630 basis points to 35.5%. This improvement was driven by stabilizing input costs and favorable foreign exchange movements, particularly the Euro-dollar exchange rate. Consequently, EBITDA grew by 67% year-on-year to ₹142 crores, achieving an EBITDA margin of 14.4%. Net profit (PAT) surged by an impressive 424% to ₹143 crores compared to ₹27 crores in Q1 FY25.
Segmental Growth and Regional Contributions
Both key business segments contributed to the growth. The Agrochemical segment's revenue increased by 25% year-on-year to ₹846 crores, with volume growth of 11%. The non-agrochemical segment saw a 31% year-on-year revenue increase to ₹139 crores, accompanied by a significant 59% volume growth. Europe remained a major contributor to overall growth, with gross margins in the region at 43%, compared to 26% in NAFTA and 28% in LATAM.
Strategic Capital Allocation and Healthy Balance Sheet
The company maintains a strong financial position, operating as a debt-free entity with cash and liquid investments totaling ₹791 crores as of June 30, 2025. Working capital days improved by 18 days to 100 days, reflecting enhanced operational efficiency. For FY26, Sharda Cropchem plans a CAPEX of ₹400-₹450 crores, primarily aimed at increasing product registrations, which stood at 2,981 as of June 30, 2025, with an additional 1,021 applications pending approval.
Outlook and Key Guidance for FY26
Management reiterated its guidance for FY26, expecting revenue to grow by 15% with EBITDA margins in the range of 15%-18%. They anticipate gross margins to remain in a similar range as Q1 FY26. While acknowledging rising freight costs due to global conflicts, the company expects foreign exchange levels to remain stable and foresees a slow but steady improvement in pricing. Management also expressed a 'gut feeling' that EBITDA margins could potentially move towards or slightly above 18%.